Evidence-based orthobiologic practice: Current evidence review and future directions
In brief
An editorial reviewing the current evidence on orthobiologics such as platelet-rich plasma (PRP), stem cells, bone marrow aspirate concentrate (BMAC) and stromal vascular fraction. The authors see promise for osteoarthritis, tendon and spine problems but highlight inconsistent protocols and results, regulatory and ethical hurdles, and the need for standardised, high-quality research.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Evidence-based orthobiologic practice: Current evidence review and future directions Authors: Jeyaraman M, Jeyaraman N, Ramasubramanian S, Balaji S, Muthu S. Link: https://www.wjgnet.com/2218-5836/full/v15/i10/908.htm Year of Publication: 2024
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

